health π¬ Long-term survival in advanced stomach cancer case
A 65-year-old man survived long-term with HER2-positive metastatic gastric adenocarcinoma in India. He was diagnosed in 2018 with aggressive stomach cancer involving the liver and experienced significant weight loss. Initial CAPOX chemotherapy plus trastuzumab led to tumor reduction, allowing surgery and maintenance therapy. Between 2021 and 2024, targeted local therapies managed two isolated recurrences while maintaining HER2 therapy. This highlights how precision medicine offers hope for advanced gastric cancer patients. π¬